Fructofen generic name recombinant human follicle stimulating hormone injection, Priligy generic name recombinant follicle stimulating hormone beta injection, both have the efficacy of promoting ovulation, the success rate of promoting ovulation is related to the individual’s sensitivity to the drug, so it is difficult to compare the success rate of the two, but you can choose according to the adverse reactions and contraindications of the use of the two drugs. Recombinant human follicle stimulating hormone injection, can induce ovulation and promote follicular growth, but some women may have headache, abdominal pain, nausea and other adverse reactions appear after use, patients suffering from hypothalamic and pituitary tumors, ovarian cysts and other diseases, as well as allergic to the drug is prohibited from use. Recombinant follicle stimulating hormone beta injection can promote ovulation after use, but there may be burning sensation at the injection site, headache, swelling, ovarian hyperstimulation syndrome and other side effects, with unexplained vaginal bleeding, primary ovarian failure and those who are allergic to the drug are prohibited from use. When using drugs to promote ovulation, if one drug is not successful in promoting ovulation, you can change another one to try. It is recommended to consult a medical professional to choose the one more suitable for your body type among the two drugs to promote ovulation in order to increase the success rate.